InvestorsHub Logo
Followers 283
Posts 1162
Boards Moderated 0
Alias Born 10/04/2020

Re: None

Friday, 12/31/2021 4:43:23 PM

Friday, December 31, 2021 4:43:23 PM

Post# of 118366
The Weill Cornell Connection

Isn't it interesting several pharmaceutical companies have a history of forming partnerships with The Weill Cornell University Medical College that aims to speed the drug discovery process of new clinical treatments. Not only this, they're supported by The Bill & Melinda Gates Foundation at the tune of at least $20M.

PROOF:
https://news.weill.cornell.edu/news/2012/06/weill-cornell-partners-with-pharmaceutical-companies-and-academic-researchers-to-speed-tuberculosis

This is what the Canary Acquisition is based on, i.e. to license their technology in the scope of the drug discovery process that's going to required $50M funding.

If this acquisition goes through, it will instantly result in a fundamental change in RGBP's Market Profile and put them on the Fast Track for advancing toward market for new clinical therapeutics based in their I.P. Portfolio which is the EXACT reason Dr. Koos made it his business this year to aggressively ACTIVATE several of his expired Patents.

IS THIS MAKING SENSE YET??? IF NOT, IT SHOULD!

Let's just hope that Acquisition goes through.

Be well and prosper...